Effect of the <i>A</i>. <i>phalerata</i> oil on the leukocyte migration induced by carrageenan in the pleurisy model in rats.

<p>Values expressed in mean ± standard error of the mean. n = 5. * P <0.05 (ANOVA / Tukey) compared with the negative control (-).</p

Anti-inflammatory, antiproliferative and cytoprotective potential of the <i>Attalea phalerata</i> Mart. ex Spreng. pulp oil - Fig 5

<p>Effect of the <i>A</i>. <i>phalerata</i> oil on the paw edema after 0.5h (A), 1h (B), 2h (C) and 4h (D) of the intraplantar carrageenan injection. Values expressed in mean ± standard error of the mean. n = 5. * P <0.05 (ANOVA / Tukey) compared with the negative control (-).</p

Effect of the <i>A</i>. <i>phalerata</i> oil in spreading of macrophages.

<p>Values expressed in mean ± standard error of the mean. n = 3. * P <0.05 (ANOVA / Tukey) compared with the negative control (-). LPS–Lipopolysaccharide.</p

Analysis of carotenoids and amino acids in <i>A</i>. <i>phalerata</i> oil employing HPLC.

<p>Analysis of carotenoids and amino acids in <i>A</i>. <i>phalerata</i> oil employing HPLC.</p

Effect of the <i>A</i>. <i>phalerata</i> oil in nitric oxide (NO) production.

<p>Values expressed in mean ± standard error of the mean. n = 33. * P <0.05 (ANOVA / Tukey) compared with the negative control (-). LPS–Lipopolysaccharide.</p

<i>In vitro</i> protective effect of <i>A</i>. <i>phalerata</i> oil under murine fibroblast cells (NIH / 3T3).

<p>The control represents untreated cells. A1, A2, A3 and A4 are evaluated treatment with doxorrubicina 0.025, 0.25, 2.5 and 25 μg mL^-1, respectively. B1, B2, B3 and B4 are evaluated treatment with APOP 250, 500, 1000 and 2000 μg mL^-1, respectively. C1-C4 are evaluated treatment combinations: (C1) used doxorrubicina on 0.025 μg mL^-1 and <i>A</i>. <i>phalerata</i> oil on 250 μg mL^-1; (C2) doxorrubicina on 0.25 μg mL^-1 and <i>A</i>. <i>phalerata</i> oil on 500 μg mL^-1; (C3) doxorrubicina on 2.5 μg mL^-1 and <i>A</i>. <i>phalerata</i> oil on 1000 μg mL^-1 (C4) doxorrubicina on 25 μg mL^-1 and <i>A</i>. <i>phalerata</i> oil on 2000 μg mL^-1. Values expressed in mean ± standard error of the mean. n = 3. * P <0.05 (ANOVA / Tukey) compared with the untreated cells.</p

Effect of the <i>A</i>. <i>phalerata</i> oil in COX1 and COX2 inhibition.

<p>Values expressed in mean ± standard error of the mean. n = 4. * P <0.05 (ANOVA / Tukey) compared with the negative control (-).</p

Effect of the <i>A</i>. <i>phalerata</i> oil on the leukocyte migration induced by carrageenan in the pleurisy model in rats.

<p>Values expressed in mean ± standard error of the mean. n = 5. * P <0.05 (ANOVA / Tukey) compared with the negative control (-).</p

Effect of the <i>A</i>. <i>phalerata</i> oil in antiproliferative activity.

<p>Effect of the <i>A</i>. <i>phalerata</i> oil in antiproliferative activity.</p